Press release
Deadline on April 20th coming up in Lawsuit for Investors in shares of Immunovant, Inc. (NASDAQ: IMVT)
A Deadline is coming up on April 20, 2021 in the lawsuit for certain investors in Immunovant, Inc. (NASDAQ: IMVT).
Investors who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and there are strict and short deadlines running. Deadline: April 20, 2021. NASDAQ: IMVT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Immunovant, Inc. (NASDAQ: IMVT) common shares between October 2, 2019 and February 1, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between October 2, 2019 and February 1, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that Health Sciences Acquisitions Corporation had performed inadequate due diligence into Legacy Immunovant prior to the Merger, and/or ignored or failed to disclose safety issues associated with IMVT-1401, that IMVT-1401 was less safe than the Company had led investors to believe, particularly with respect to treating TED and WAIHA, that the foregoing foreseeably diminished IMVT-1401's prospects for regulatory approval, commercial viability, and profitability, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on April 20th coming up in Lawsuit for Investors in shares of Immunovant, Inc. (NASDAQ: IMVT) here
News-ID: 2260765 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for IMVT
Investigation announced for NASDAQ: IMVT investors over possible Wrongdoing at I …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Immunovant, Inc..
Investors who are current long term investors in Immunovant, Inc. (NASDAQ: IMVT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: IMVT stocks follows a lawsuit filed against Immunovant, Inc. over…
Lawsuit filed for Investors in shares of Immunovant, Inc. (NASDAQ: IMVT)
An investor, who purchased shares of Immunovant, Inc. (NASDAQ: IMVT), filed a lawsuit over alleged violations of Federal Securities Laws by Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation.
Investors who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and for certain investors are short and strict deadlines running. Deadline: April 20, 2021. NASDAQ: IMVT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
New York…
Investigation announced for NASDAQ: IMVT shares over possible Wrongdoing at Immu …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Immunovant, Inc.
Investors who purchased shares of Immunovant, Inc. (NASDAQ: IMVT) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Immunovant, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
New York based Immunovant,…
